You have 9 free searches left this month | for more free features.

refractory anemia with ringed sideroblasts

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

Completed
  • AML
  • +11 more
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 31, 2019

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +16 more
  • iodine I 131 monoclonal antibody BC8
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 8, 2019

Cancer in Inherited Bone Marrow Failure Syndromes

Recruiting
  • Diamond Blackfan Anemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 24, 2023

    Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia

    Completed
    • Adult Acute Myeloid Leukemia in Remission
    • +29 more
    • Fludarabine Phosphate
    • +5 more
    • Tucson, Arizona
    • +9 more
    Dec 18, 2019

    Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)

    Completed
    • Chronic Myelomonocytic Leukemia
    • +7 more
    • flow cytometry
    • +7 more
    • Cleveland, Ohio
    • +1 more
    Feb 21, 2019

    Mean Platelet Volume and Its Relation to Risk Stratification of

    Completed
    • Myelodysplastic Syndromes
      • (no location specified)
      Jan 21, 2022

      MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

      Completed
      • Myelodysplastic Syndromes (MDS)
      • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
      • Chicago, Illinois
      • +11 more
      Apr 4, 2022

      MDS Trial in Beijing (Roxadustat, Luspatercept)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
        Peking union medical college hospital
      Aug 17, 2023

      Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

      Recruiting
      • Primary Myelofibrosis
      • +9 more
      • Observational
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Apr 11, 2022

      Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in

      Completed
      • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
      • +13 more
      • Salt Lake City, Utah
      • +2 more
      Jan 15, 2020

      MDS Trial in China, Japan (Luspatercept)

      Recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
      • +33 more
      Aug 16, 2022

      MDS, Anemia Trial in Germany (Luspatercept Injection)

      Recruiting
      • Myelodysplastic Syndromes
      • Anemia
      • Luspatercept Injection
      • Berlin, Germany
      • +18 more
      Jan 25, 2023

      MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

      Recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Luspatercept Injection [Reblozyl]
      • Alessandria, Italy
      • +22 more
      Jun 20, 2023

      MDS Trial in Worldwide (Luspatercept, Placebo)

      Completed
      • Myelodysplastic Syndromes
      • Stanford, California
      • +73 more
      Nov 19, 2021

      MDS Trial in Beijing (Lenalidomide, Azacitidine)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
        Peking union medical college hospital
      Aug 16, 2023

      Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

      Completed
      • Myeloproliferative Disorders
      • +4 more
      • T-cell replete PBPC allograft
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 12, 2022

      Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 6, 2023

      Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Tumors Trial in Tampa (busulfan,

      Completed
      • Chronic Myeloproliferative Disorders
      • +4 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute at Universit
      Dec 9, 2020

      Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in United States (arsenic trioxide)

      Terminated
      • Leukemia
      • +2 more
      • arsenic trioxide
      • Tucson, Arizona
      • +7 more
      Oct 2, 2020

      MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

      Recruiting
      • MDS
      • Myelodysplastic Syndromes
      • Luspatercept Injection [Reblozyl]
      • Eprex
      • Amiens, France
      • +30 more
      May 19, 2022

      Leukemia, MDS Trial in Los Angeles (arsenic trioxide, azacitidine)

      Terminated
      • Leukemia
      • Myelodysplastic Syndromes
      • Los Angeles, California
        Jonsson Comprehensive Cancer Center at UCLA
      Jul 29, 2020

      Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

      Terminated
      • Refractory Aplastic Anemia
      • Tianjin, Tianjin, China
        Regenerative Medicine Center
      Aug 25, 2022

      Warm Autoimmune Hemolytic Anemia Trial in Beijing (Sirolimus)

      Not yet recruiting
      • Warm Autoimmune Hemolytic Anemia
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 21, 2023